Chimeric receives $1.62M advance on FY26 R&D tax incentive

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited